The European Medicines Agency (EMA) has granted orphan drug designation to rilzabrutinib, Sanofi’s...
Author - Abby Davey
Bayer Foundation and United Nations Capital Development Fund...
Bayer Foundation and the United Nations Capital Development Fund (UNCDF) partner to launch the...
Hatteras Venture Partners Raises Over $200 Million in Capital...
Hatteras Venture Partners announced the final closings of Hatteras Venture Partners VII (HVP VII)...